Mayukh Choudhury

Mayukh Choudhury, Ph.D. has a diverse work experience spanning over different research and project management roles. Mayukh currently works as a Scientist at Celerion, specializing in protocol design and development since September 2020. In their previous role as a Project Coordinator at Innovaderm Research Inc. from February 2019 to January 2020, Mayukh was responsible for scheduling project meetings, coordinating training documentation, and communicating with key opinion leaders and healthcare professionals. Mayukh also worked as an Interpreter at the Immigration and Refugee Board of Canada from January 2018 to August 2019.

Mayukh has a strong background in research, having worked as a Postdoctoral Researcher at Concordia University from January 2017 to October 2017. In this role, they served as a laboratory manager and scientific advisor for projects focused on psychology, behavior, and addiction. Mayukh pioneered immunohistological and imaging techniques, developed standard operating procedures, and provided training to team members. Prior to that, they worked as a Postdoctoral Fellow at the Institut de recherches cliniques de Montréal (IRCM) from May 2016 to November 2016, leading a project on developmental neuroscience and achieving publication through a new biochemical approach.

Before their postdoctoral work, Mayukh was a Graduate Student Researcher at CHU Sainte-Justine Research Centre from September 2010 to December 2015. Their research focused on developmental neuroscience, particularly in relation to autism and epilepsy. Mayukh earned awards for their presentations and made significant contributions to the field, including the development of an innovative technique for screening genetic mutations in epilepsy patients. Mayukh's career also includes a role as a Project Intern at the Indian Council of Medical Research from 2008 to 2009.

Overall, Mayukh Choudhury, Ph.D. has a broad range of experience in research, project coordination, and scientific leadership across multiple organizations.

Mayukh Choudhury, Ph.D., has an extensive educational background in biomedical science and pharmaceutical management. Mayukh obtained their Doctor of Philosophy (Ph.D.) in Biomedical Science with a focus on Neurodevelopmental Disorders, Autism, and Inhibitory Circuits from Université de Montréal, where they studied from 2010 to 2016. Prior to that, they completed a Master of Science (MS) degree in Biochemistry at Concordia University from 2009 to 2010, and a Master of Science (MSc) degree in Biotechnology at Vellore Institute of Technology from 2006 to 2008.

In addition to their academic degrees, Mayukh Choudhury has pursued further certifications to enhance their professional skills. Mayukh has completed courses such as "Delivering an Authentic Elevator Pitch," "Time Management Fundamentals," and "Communicating with Confidence" through LinkedIn. Mayukh has also obtained certifications in "The Complete SQL Bootcamp" and "Beginner to Pro in Excel: Financial Modeling and Valuation" from Udemy. Additionally, they have acquired knowledge in Drug Development through Coursera Course Certificates and is CSA Industry trained.

Furthermore, Mayukh Choudhury has gained expertise in the field of clinical trials and regulatory affairs. Mayukh has completed a Graduate Diploma in Pharmaceutical & Healthcare Management and Innovation from Queen's University in 2020. Mayukh also holds a Graduate Diploma (D.E.S.S.) in Drug Development, focusing on Pharmacology, Clinical Trials, Regulatory Affairs, and HEOR (Health Economics and Outcomes Research) from Université de Montréal.

Mayukh Choudhury's educational background and certifications reflect their strong foundation in biomedical science, neurodevelopmental disorders, autism, pharmaceutical and healthcare management, and drug development.